litlas
Log inCreate account

P. James B. Dyck

Active 1963–2025

152
Papers
31,011
Citations
98
h-index
149
i10-index

Citations

Citations per year for P. James B. Dyck1966: 1 citations1968: 1 citations1969: 3 citations1970: 3 citations1971: 4 citations1972: 7 citations1973: 6 citations1974: 13 citations1975: 5 citations1976: 7 citations1977: 3 citations1978: 4 citations1979: 9 citations1980: 17 citations1981: 10 citations1982: 7 citations1983: 24 citations1984: 18 citations1985: 33 citations1986: 48 citations1987: 47 citations1988: 56 citations1989: 51 citations1990: 50 citations1991: 58 citations1992: 57 citations1993: 69 citations1994: 80 citations1995: 116 citations1996: 99 citations1997: 81 citations1998: 104 citations1999: 152 citations2000: 105 citations2001: 110 citations2002: 115 citations2003: 138 citations2004: 139 citations2005: 211 citations2006: 127 citations2007: 129 citations2008: 140 citations2009: 116 citations2010: 170 citations2011: 156 citations2012: 147 citations2013: 172 citations2014: 184 citations2015: 186 citations2016: 155 citations2017: 172 citations2018: 150 citations2019: 870 citations2020: 976 citations2021: 776 citations2022: 580 citations2023: 440 citations2024: 742 citations2025: 388 citations2026: 11 citations1967: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,591 citing papers, 29% of this breakdownUnited Kingdom: 784 citing papers, 8.8% of this breakdownGermany: 534 citing papers, 6% of this breakdownItaly: 517 citing papers, 5.8% of this breakdownChina: 445 citing papers, 5% of this breakdownFrance: 343 citing papers, 3.8% of this breakdownCanada: 341 citing papers, 3.8% of this breakdownJapan: 320 citing papers, 3.6% of this breakdownNetherlands: 281 citing papers, 3.1% of this breakdownAustralia: 254 citing papers, 2.8% of this breakdownSpain: 210 citing papers, 2.4% of this breakdownSweden: 170 citing papers, 1.9% of this breakdown
0%29%Other 24%

Institutions

Fields

  • Medicine49.7%
  • Biochemistry, Genetics and Molecular Biology34.9%
  • Neuroscience10.9%
  • Engineering1.1%
  • Immunology and Microbiology0.8%
  • Materials Science0.6%
  • Other2%

Topics

  • Pain Mechanisms and Treatments6.6%
  • Amyloidosis: Diagnosis, Treatment, Outcomes4.4%
  • Peripheral Neuropathies and Disorders4.4%
  • RNA Interference and Gene Delivery4%
  • Hereditary Neurological Disorders3.4%
  • Botulinum Toxin and Related Neurological Disorders3%
  • Other74.2%

Coauthors

All papers

Open in search
  1. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    Authors: David Adams, Alejandra González‐Duarte, William O’Riordan, Chih‐Chao Yang, Mitsuharu Ueda, Arnt V. Kristen, Ivailo Tournev, Hartmut Schmidt, Teresa Coelho, John L. Berk, Kon-Ping Lin, Giuseppe Vita, Shahram Attarian, Violaine Planté‐Bordeneuve, Michelle M. Mezei, Josep M. Campistol, Juan Buades, Thomas H. Brannagan, Byoung J. Kim, Jeeyoung Oh, Yeşim Parman, Yoshiki Sekijima, Philip N. Hawkins, Scott D. Solomon, Michael Polydefkis, P. James B. Dyck, Pritesh J. Gandhi, Sunita Goyal, Jihong Chen, Andrew Strahs, Saraswathy V. Nochur, Marianne T. Sweetser, Pushkal Garg, Akshay Vaishnaw, Jared Gollob, Ole B. Suhr - New England Journal of Medicine 2018 cited by 2,918

  2. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Authors: Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk, Michael Polydefkis, P. James B. Dyck, Annabel K. Wang, Violaine Planté‐Bordeneuve, Fábio Barroso, Giampaolo Merlini, Laura Obici, Morton Scheinberg, Thomas H. Brannagan, William J. Litchy, Carol Whelan, Brian Drachman, David Adams, Stephen B. Heitner, Isabel Conceição, Hartmut Schmidt, Giuseppe Vita, Josep M. Campistol, Josep Gámez, Peter D. Gorevic, Edward Gane, Amil M. Shah, Scott D. Solomon, Brett P. Monia, Steven G. Hughes, T. Jesse Kwoh, Bradley McEvoy, Shiangtung W. Jung, Brenda F. Baker, Elizabeth J. Ackermann, Morie A. Gertz, Teresa Coelho - New England Journal of Medicine 2018 cited by 1,422

  3. Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

    Authors: Teresa Coelho, Wilson Marques, Noel R. Dasgupta, Chi‐Chao Chao, Yeşim Parman, Marcondes C. França, Yuh‐Cherng Guo, Jonas Wixner, Long‐Sun Ro, Cristian Calandra, Pedro André Kowacs, John L. Berk, Laura Obici, Fábio Barroso, Markus Weiler, Isabel Conceição, Shiangtung W. Jung, Gustavo Büchele, Michela Brambatti, Jersey Chen, Steven G. Hughes, Eugene Schneider, Nicholas J. Viney, Ahmad Masri, Morie R. Gertz, Yukio Ando, Julian D. Gillmore, Sami Khella, P. James B. Dyck, Márcia Waddington‐Cruz, NEURO-TTRansform Investigators, Anna Mazzeo, Aikaterini Papagianni, Mazen M. Dimachkie, Ioannis Zaganas, Edward Gane, Marco Luigetti, Lucía Galán Dávila, Michelle M. Mezei, Juan González Moreno, Pascal Cintas, Davide Pareyson, Rebecca Traub, Julie Khoury, Conrado J. Estol, Merrilee Needham, David Adams, Michael Polydefkis, Thomas H. Brannagan, Vera Bril, Shahram Attarian, Marcelo Rugiero, B. Jane Distad, Eleni Zamba Papanicolaou, Kon‐Ping Lin, Merrill D. Benson, Morton Scheinberg - JAMA 2023 cited by 207

  4. Repurposing Diflunisal for Familial Amyloid Polyneuropathy

    Authors: John L. Berk, Ole B. Suhr, Laura Obici, Yoshiki Sekijima, Steven R. Zeldenrust, Taro Yamashita, Michael A. Heneghan, Peter D. Gorevic, William J. Litchy, Janice F. Wiesman, Erik Nordh, M. Di Corato, Alessandro Lozza, Andrea Cortese, Jessica Robinson‐Papp, Theodore Colton, Denis Rybin, Alice Bisbee, Yukio Ando, Shu-ichi Ikeda, David C. Seldin, Giampaolo Merlini, Martha Skinner, Jeffery W. Kelly, P. James B. Dyck - JAMA 2013 cited by 701

  5. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

    Authors: P. James B. Dyck, K. M. Kratz, Jeannine L. Karnes, William J. Litchy, Ronald Klein, John M. Pach, Derrick Wilson, P. C. OʼBrien, L. Joseph Melton - Neurology 1993 cited by 1,483

  6. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

    Authors: Morie A. Gertz, Merrill D. Benson, P. James B. Dyck, Martha Grogan, Terresa Coelho, Márcia Waddington‐Cruz, John L. Berk, Violaine Planté‐Bordeneuve, Hartmut Schmidt, Giampaolo Merlini - Journal of the American College of Cardiology 2015 cited by 473

  7. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

    Authors: M. Backonja, Nadine Attal, Ralf Baron, Didier Bouhassira, Mark Drangholt, P. James B. Dyck, Robert R. Edwards, Roy Freeman, Richard H. Gracely, Maija Haanpää, Per Hansson, Samar M. Hatem, Elena K. Krumova, Troels S. Jensen, Christoph Maier, Gérard Mick, Andrew S.C. Rice, Roman Rolke, Rolf‐Detlef Treede, Jordi Serra, Thomas Toelle, V. Tugnoli, David Walk, Mark S. Walalce, Mark A. Ware, David Yarnitsky, Dan Ziegler - Pain 2013 cited by 560

  8. Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy

    Authors: Dan Ziegler, Phillip A. Low, William J. Litchy, Andrew J.M. Boulton, Aaron I. Vinik, Roy Freeman, Р. Р. Самигуллин, Hans Tritschler, Ullrich Munzel, Joachim Maus, Klemens Schütte, P. James B. Dyck - Diabetes Care 2011 cited by 389

  9. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis

    Authors: Antonia Carroll, P. James B. Dyck, Mamede de Carvalho, Marina Kennerson, Mary M. Reilly, Matthew C. Kiernan, Steve Vucic - Journal of Neurology Neurosurgery & Psychiatry 2022 cited by 111

  10. Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy

    Authors: Dan Ziegler, Ametov As, А Н Баринов, P. James B. Dyck, Irina Gurieva, Phillip A. Low, Ullrich Munzel, N. N. Yakhno, Itamar Raz, Maria Novosadova, Joachim Maus, Р. Р. Самигуллин - Diabetes Care 2006 cited by 549

  11. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss

    Authors: Christopher J. Klein, Maria Victoria Botuyan, Yanhong Wu, Christopher J. Ward, Garth A. Nicholson, Simon Hammans, Kaori Hojo, Hiromitch Yamanishi, Adam R. Karpf, Douglas C. Wallace, Mariella Simon, Cecilie M. Lander, Lisa A Boardman, Julie M. Cunningham, Glenn E. Smith, William J. Litchy, Benjamin Boes, Elizabeth J. Atkinson, Sumit Middha, P. James B. Dyck, Joseph E. Parisi, Georges Mer, David I Smith, P. James B. Dyck - Nature Genetics 2011 cited by 395

  12. Rapid progression of familial amyloidotic polyneuropathy

    Authors: David Adams, Teresa Coelho, Laura Obici, Giampaolo Merlini, Zoïa Mincheva, Narupat Suanprasert, Brian R. Bettencourt, Jared Gollob, Pritesh J. Gandhi, William J. Litchy, P. James B. Dyck - Neurology 2015 cited by 153

  13. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype

    Authors: Emily K. Mathey, Susanna B. Park, Richard AC Hughes, John D. Pollard, Patricia J. Armati, Michael Barnett, Bruce Taylor, P. James B. Dyck, Matthew C. Kiernan, Cindy Lin - Journal of Neurology Neurosurgery & Psychiatry 2015 cited by 426

  14. Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus

    Authors: Parinya Samakkarnthai, Jad Sfeir, Elizabeth J. Atkinson, Sara J. Achenbach, Paul W. Wennberg, P. James B. Dyck, Amanda Tweed, Tammie L. Volkman, Shreyasee Amin, Joshua N. Farr, Adrian Vella, Matthew T. Drake, Sundeep Khosla - The Journal of Clinical Endocrinology & Metabolism 2020 cited by 79

  15. Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Authors: Teresa Coelho, Yukio Ando, Merrill D. Benson, John L. Berk, Márcia Waddington‐Cruz, P. James B. Dyck, Julian D. Gillmore, Sami Khella, William J. Litchy, Laura Obici, Cecília Monteiro, Li-Jung Tai, Nicholas J. Viney, Gustavo Büchele, Michela Brambatti, Shiangtung W. Jung, Louis O’Dea, Sotirios Tsimikas, Eugene Schneider, Richard S. Geary, Brett P. Monia, Morie A. Gertz - Neurology and Therapy 2021 cited by 56

  16. Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non‐systemic vasculitic neuropathy: executive summary

    Authors: Michael P. Collins, P. James B. Dyck, Gary Gronseth, Loı̈c Guillevin, Robert D. M. Hadden, Dieter Heuß, Jean‐Marc Léger, N. C. Notermans, John D. Pollard, Gérard Saïd, Gen Sobue, Alexander F. J. E. Vrancken, John T. Kissel - Journal of the Peripheral Nervous System 2010 cited by 281

  17. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen

    Authors: Teresa Coelho, Márcia Waddington‐Cruz, Chi‐Chao Chao, Yeşim Parman, Jonas Wixner, Markus Weiler, Fábio Barroso, Noel R. Dasgupta, Shiangtung W. Jung, Eugene Schneider, Nicholas J. Viney, P. James B. Dyck, Yukio Ando, Julian D. Gillmore, Sami Khella, Morie A. Gertz, Laura Obici, John L. Berk - Neurology and Therapy 2022 cited by 29

  18. Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry

    Authors: P. James B. Dyck, William R. Sherman, Loretta M. Hallcher, F. John Service, Peter C. O’Brien, Lucy A. Grina, Pasquale Palumbo, C Swanson - Annals of Neurology 1980 cited by 511

  19. Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7

    Authors: P. James B. Dyck, Alejandra González‐Duarte, Laura Obici, Michael Polydefkis, Janice F. Wiesman, Ilia Antonino, William J. Litchy, P. James B. Dyck - Journal of the Neurological Sciences 2019 cited by 113

  20. Multifocal motor neuropathy: controversies and priorities

    Authors: Wei Zhen Yeh, P. James B. Dyck, Leonard H. van den Berg, Matthew C. Kiernan, Bruce Taylor - Journal of Neurology Neurosurgery & Psychiatry 2019 cited by 107

  21. Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update

    Authors: Thomas H. Brannagan, Teresa Coelho, Annabel K. Wang, Michael Polydefkis, P. James B. Dyck, John L. Berk, Brian Drachman, Peter D. Gorevic, Carol Whelan, Isabel Conceição, Violaine Planté‐Bordeneuve, Giampaolo Merlini, Laura Obici, Josep Maria Campistol Plana, Josep Gámez, Arnt V. Kristen, Anna Mazzeo, Luca Gentile, Arvind Narayana, Kemi Olugemo, Peter Aquino, Merrill D. Benson, Morie A. Gertz, for the NEURO-T. T. R. Open-Label Extension Investigators - Journal of Neurology 2022 cited by 36

  22. Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial

    Authors: Thomas H. Brannagan, A. K. Wang, Teresa Coelho, Márcia Waddington‐Cruz, Michael Polydefkis, P. James B. Dyck, Violaine Planté‐Bordeneuve, John L. Berk, Fábio Barroso, Giampaolo Merlini, Isabel Conceição, Stephen G. Hughes, Jesse Kwoh, Shiangtung W. Jung, Spencer Guthrie, M. Pollock, M. D. Benson, Morie A. Gertz, for the NEURO‐TTR open‐label extension investigators - European Journal of Neurology 2020 cited by 71

  23. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4

    Authors: Han‐Xiang Deng, Christopher J. Klein, Jianhua Yan, Yong Shi, Yanhong Wu, Faisal Fecto, Hau‐Jie Yau, Yi Yang, Hong Zhai, Nailah Siddique, E. Tessa Hedley‐Whyte, Robert DeLong, Marco Martina, P. James B. Dyck, Teepu Siddique - Nature Genetics 2009 cited by 273

  24. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial

    Authors: P. James B. Dyck, P. James B. Dyck, Carol J. Overland, Phillip A. Low, William J. Litchy, Jenny L. Davies, P. James B. Dyck, P. James B. Dyck, Peter C. O’Brien - Muscle & Nerve 2010 cited by 231